Related references
Note: Only part of the references are listed.Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?
Lih Yin Tan et al.
CLINICAL & TRANSLATIONAL IMMUNOLOGY (2017)
Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects
Romain Daillere et al.
IMMUNITY (2016)
Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy
Christina Pfirschke et al.
IMMUNITY (2016)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Marie Vetizou et al.
SCIENCE (2015)
Cancer and the gut microbiota: An unexpected link
Laurence Zitvogel et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
Christiane Meyer et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Transcriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Jia Xue et al.
IMMUNITY (2014)
Vaccine-induced myeloid cell population dampens protective immunity to SIV
Yongjun Sui et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Differently immunogenic cancers in mice induce immature myeloid cells that suppress CTL in vitro but not in vivo following transfer
Karin Schmidt et al.
BLOOD (2013)
Therapeutic regulation of myeloid-derived suppressor cells and immune response to cancer vaccine in patients with extensive stage small cell lung cancer
Cristina Iclozan et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Clinical and immunologic responses in melanoma patients vaccinated with MAGE-A3-genetically modified lymphocytes
Vincenzo Russo et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Virus-induced hepatocellular carcinomas cause antigen-specific local tolerance
Gerald Willimsky et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Activated human hepatic stellate cells induce myeloid derived suppressor cells from peripheral blood monocytes in a CD44-dependent fashion
Bastian Hoechst et al.
JOURNAL OF HEPATOLOGY (2013)
CpG oligodeoxynucleotide induces bone marrow precursor cells into myeloid-derived suppressor cells
Jie Chen et al.
MOLECULAR MEDICINE REPORTS (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Sophie Viaud et al.
SCIENCE (2013)
Immunology in the clinic review series; focus on cancer: tumour-associated macrophages: undisputed stars of the inflammatory tumour microenvironment
P. Allavena et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
Yuko Shirota et al.
JOURNAL OF IMMUNOLOGY (2012)
Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells
Bastian Hoechst et al.
BLOOD (2011)
CpG Blocks Immunosuppression by Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Christine Zoglmeier et al.
CLINICAL CANCER RESEARCH (2011)
Myeloid derived suppressor cells in human diseases
Tim F. Greten et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
Chemokines: a new dendritic cell signal for T cell activation
Christoph A. Thaiss et al.
FRONTIERS IN IMMUNOLOGY (2011)
Selective Depletion of Foxp3+ Regulatory T Cells Improves Effective Therapeutic Vaccination against Established Melanoma
Katjana Klages et al.
CANCER RESEARCH (2010)
Efficient Treg depletion induces T-cell infiltration and rejection of large tumors
Xingrui Li et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Randomized Phase II Trial of All-Trans-Retinoic Acid With Chemotherapy Based on Paclitaxel and Cisplatin As First-Line Treatment in Patients With Advanced Non-Small-Cell Lung Cancer
Oscar Arrieta et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Low-dose Cyclophosphamide Treatment Impairs Regulatory T Cells and Unmasks AFP-specific CD4+ T-cell Responses in Patients With Advanced HCC
Tim F. Greten et al.
JOURNAL OF IMMUNOTHERAPY (2010)
Alternative cross-priming through CCL17-CCR4-mediated attraction of CTLs toward NKT cell-licensed DCs
Verena Semmling et al.
NATURE IMMUNOLOGY (2010)
Cross-priming in health and disease
Christian Kurts et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor
Bastian Hoechst et al.
HEPATOLOGY (2009)
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4+CD25+Foxp3+ T cells
Bastian Hoechst et al.
GASTROENTEROLOGY (2008)
Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness
Gerald Willimsky et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Retinoic acid increases Foxp3+ regulatory T cells and inhibits development of Th17 cells by enhancing TGF-β-driven Smad3 signaling and inhibiting IL-6 and IL-23 receptor expression
Sheng Xiao et al.
JOURNAL OF IMMUNOLOGY (2008)
Analysis and characterization of antitumor T-cell response after administration of dendritic cells loaded with allogeneic tumor lysate to metastatic melanoma patients
Nadege Bercovici et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Immunotherapy for Advanced Melanoma
Lei Fang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Long-lived antitumor CD8+ lymphocytes for adoptive therapy generated using an artificial antigen-presenting cell
Marcus O. Butler et al.
CLINICAL CANCER RESEARCH (2007)
Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses
Olivier Adotevi et al.
CLINICAL CANCER RESEARCH (2006)
Immature myeloid cells and cancer-associated immune suppression
S Kusmartsev et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Share Paper
